The Congressional Budget Office's Case for Comparative Effectiveness
This article was originally published in RPM Report
Executive Summary
There's a lot of support for a federal comparative effectiveness agency, but would it actually curtail health care spending? The head of CBO says yes--when paired with the appropriate incentives.
You may also be interested in...
Man on a Mission
Congressional Budget Office director Peter Orszag is becoming the apostle of comparative effectiveness research. Orszag believes a national effort will reduce health care costs over the long term-and he's telling anyone who will listen.
Comparative Effectiveness: The Next Gatekeeper to Commercial Success
The hot new buzzword with policymakers is comparative clinical effectiveness, and everyone has an idea on how to make it work. But major questions remain: what might a national effort look like? And will payors use it to restrict access to new drugs?
Comparative Effectiveness: The Next Gatekeeper to Commercial Success
The hot new buzzword with policymakers is comparative clinical effectiveness, and everyone has an idea on how to make it work. But major questions remain: what might a national effort look like? And will payors use it to restrict access to new drugs?